2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$6.58+$0.10 (+1.48%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.4BMarket Cap
- -42.86%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$6.58+$0.10 (+1.48%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.48 | ||
Change | -$0.17 (-2.56%) | ||
Open | $6.69 | ||
High | $6.75 | ||
Low | $6.38 | ||
Previous Close | $6.65 | ||
Volume | 2,491,836 | ||
30-Day Average Volume | 3,972,808 | ||
1-Week Change | -10.00% | ||
1-Month Change | -35.14% | ||
1-Year Change | -42.86% | ||
3-Year Change | 175.74% | ||
5-Year Change | -40.17% | ||
Fundamentals | |||
Shares Outstanding | 219.6M | ||
Total Assets | $671.3M | ||
Market Cap | $1.4B | ||
Enterprise Value | $897.3M | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$78.8M | ||
Free Cash Flow | -$70.6M | ||
EBIT | -$78.8M | ||
EBITDA | -$76.9M | ||
Net Working Capital | $595.3M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 67 | ||
P/B | 3 | ||
P/E | -19 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue